WebSep 24, 2024 · Even Gauci et al. showed that approximately three-quarters of patients presented with diabetic ketoacidosis . Most immunotherapy-related adverse events … WebMar 25, 2024 · Background. Pembrolizumab is a checkpoint inhibitor that targets the programmed cell death-1 receptor (PD-1) and has shown to be effective against several malignancies, including lung cancer. However, life-threatening immune-related adverse events can result from these immunotherapy treatments. Case presentation. A …
肺腺癌免疫治疗引起糖尿病酮症酸中毒1例报道
WebThe use of these drugs may be contraindicated in patients with known infectious diseases. All patients should be instructed to immediately report any signs or symptoms suggesting infection such as fever, sore throat, or local infection during antineoplastic therapy. Close clinical monitoring of hematopoietic function is recommended. References WebMarchand et al. reported that the clinical manifestations differ depending on the presence or absence of a history of type 2 diabetes mellitus, in that the former often do not develop complicating diabetic ketoacidosis and the serum C-peptide levels remain measurable [36,37]. Therefore, we may consider the present patient as a case of IMD in ... daddy\u0027s birthday lyrics young thug
Diabetic Ketoacidosis Diabetes CDC
WebOct 1, 2024 · A severe case of diabetic ketoacidosis and new-onset type 1 diabetes mellitus associated with anti-glutamic acid decarboxylase antibodies following immunotherapy with pembrolizumab Am. J. Case Rep. , 22 ( 2024 ) , Article e931702 , 10.12659/ajcr.931702 WebNew-onset insulin-dependent diabetes developed after a median of four cycles or 5 months; 67% presented with diabetic ketoacidosis and 83% with low or undetectable C-peptide. Autoantibodies were elevated in 5/7 … http://jms.fudan.edu.cn/CN/abstract/abstract2303.shtml daddy\u0027s beach club events